🖼

Figure 1 — Clarifying off-target effects for torcetrapib using network pharmacology and rev

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-323a4a68639d-1
Figure 1 — Clarifying off-target effects for torcetrapib using network pharmacology and rev
Figure 1Figure 1
Chemical structure of torcetrapib. ChemSpider ( http://www.chemspider.com/ ) ID: 140123; Molecular Formula: C 26 H 25 F 9 N 2 O 4 ; Average mass: 600.473328 Da; Systematic name: Ethyl(2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-1(2H)-quinolinecarboxylate.
PubMed: paper-323a4a68639d
Metadata
pmidpaper-323a4a68639d
captionChemical structure of torcetrapib. ChemSpider ( http://www.chemspider.com/ ) ID: 140123; Molecular Formula: C 26 H 25 F 9 N 2 O 4 ; Average mass: 600.473328 Da; Systematic name: Ethyl(2R,4S)-4-{[3,5-
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC3547811/bin/1752-0509-6-152-1.jpg
paper_titleClarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.
figure_labelFigure 1
figure_number1
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.